Independent lung ventilation for the management of acute allograft rejection after single-lung transplantation for end-stage emphysema

J Med Invest. 2022;69(3.4):323-327. doi: 10.2152/jmi.69.323.

Abstract

Background : We herein report the use of independent lung ventilation (ILV) for managing acute allograft rejection after single-lung transplantation (SLT) for end-stage emphysema. Case presentation : A 54-year-old woman was transferred to our hospital with severe hypoxemia and respiratory distress due to unilateral lung disease with diffuse alveolar damage in the right donor lung associated with acute allograft rejection and with hyperinflation of the left native lung due to emphysema. She was unresponsive to immunosuppressive medications and conventional ventilation strategies, so different ventilator settings for each lung were required. A double-lumen endotracheal tube (DLT) was inserted, and ILV was initiated. The right lung was ventilated with high positive end-expiratory pressure (PEEP), intended for lung recruitment, and the left lung was ventilated with lung protective strategies using a low tidal volume and low levels of PEEP to avoid hyperinflation. Two days later, her lung function was dramatically improved, and the DLT was replaced with a single-lumen endotracheal tube. Gas exchange was maintained, and she was successfully weaned from mechanical ventilation on intensive-care unit day 15. Conclusions : ILV appears to be effective and safe for managing acute allograft rejection after SLT for emphysema. J. Med. Invest. 69 : 323-327, August, 2022.

Keywords: acute allograft rejection; emphysema; independent lung ventilation; single-lung transplantation.

Publication types

  • Case Reports

MeSH terms

  • Allografts
  • Emphysema*
  • Female
  • Humans
  • Lung
  • Lung Transplantation*
  • Middle Aged
  • Pulmonary Emphysema* / surgery
  • Respiration, Artificial